What is your approach to localized pancreatic cancer that would otherwise be resectable, except for poor patient characteristics?
ex. age, surgical risk, and/or performance status
Answer from: Medical Oncologist at Academic Institution
Tough question—since there is no prospectively validated phase III data to guide us in such situations, we've adopted an approach that utilizes bi-modality treatment sequencing, punctuated with aggressive supportive care and frequent multidisciplinary evaluation (q 2 months) to re-assess eligi...
Sign in or Register to read more